Is a complete PTHS research report available?

No complete published report is available for Pelthos Therapeutics Inc. (PTHS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Pelthos Therapeutics Inc. (PTHS)

NYSEAMERICAN: PTHS · USD

$25.9

-2.48 (-8.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PTHS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	90.1M
Revenue (ttm)	27.7M
Net income (ttm)	-51.6M
EPS (ttm)	-$20.2
Shares out	3.5M
Volume	206,211
Beta	3.13
Price target	$57.7	+122.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 27.7M
Net income (ttm): -51.6M
EPS (ttm): -$20.2
Market cap: 90.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PTHS indicators

Market & fundamental data

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001919246
Company name	Pelthos Therapeutics Inc.
Country	United States
Country code	US
Cusip	171126204
Employees	92
Employees Change	81%
Employees Change Percent	736.4
Enterprise value	$116.1M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US1711262048
Last refreshed	2026-07-25
Market cap	$90.1M
Market cap category	Micro-Cap
Price	$25.92
Price currency	USD
Rev Per Employee	301,097.83x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2836
Symbol	PTHS
Website	https://pelthos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-54.24%
EV Sales Forward	1.48x
EV/Sales	4.19x
FCF yield	-37.2%
P/B ratio	2.73x
P/S ratio	3.43x
PS Forward	1.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-154.01%
Gross margin	75.16%
Gross Profit	$20.8M
Net Income	$-51.6M
Net Income Growth Years	0%
Pretax Margin	-212.9%
Profit Margin	-186.24%
Profit Per Employee	$-560,750
ROA	-36.45
ROCE	-35.44
ROE	-333.8
ROIC	-61.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	18.53%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.38
Assets	$145.4M
Cash	$32M
Current Assets	$69.8M
Current Liabilities	$25M
Debt	$52.9M
Debt Equity	$1.51
Equity	$35.1M
Interest Coverage	-8.16
Liabilities	$110.3M
Long Term Assets	$75.6M
Long Term Liabilities	$85.3M
Net Cash	$-21M
Net Cash By Market Cap	$-22.03
Net Debt Equity	$0.6
Tangible Book Value	$-28M
Tangible Book Value Per Share	$-8.31
WACC	16.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.79
Net Working Capital	$13.5M
Quick ratio	1.75
Working Capital	$44.8M
Working Capital Turnover	$1.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-330.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	18.52%
200-day SMA	26.17
50-day SMA	27.02
50-day SMA vs 200-day SMA	50over200
All Time High	60
All Time High Change	-56.8%
All Time High Date	2024-02-16
All Time Low	4.5
All Time Low Change	476%
All Time Low Date	2024-11-19
ATR	1.98
Beta	3.13
Beta1y	1.72
Beta2y	1.77
Ch YTD	-16.39
High	28.81
High52	37.5
High52 Date	2025-11-06
High52ch	-30.88%
Low	25.55
Low52	16.5
Low52 Date	2025-08-13
Low52ch	57.09%
Ma50ch	-4.08%
Price vs 200-day SMA	-0.97%
RSI	46.11
RSI Monthly	46.98
RSI Weekly	51.21
Sharpe ratio	0.68x
Sortino ratio	1.18
Total Return	-330.61%
Tr YTD	-16.39
Tr1m	-12.14%
Tr1w	-3.96%
Tr3m	11.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	2
Analyst Price Target Top	$57
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-2.96
Earnings Revenue Estimate	15,386,112x
Operating Income	$-42.7M
Operating margin	-154
Price target	$57.71
Price Target Change	$123
Price Target Change Top	$120

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,394,609%
Float Percent	40.13%
Net Borrowing	45,019,000
Shares Insiders	9.33%
Shares Institutions	28.19%
Shares Out	3,475,645
Shares Qo Q	4.98%
Shares Yo Y	330.61%
Short Float	1.99%
Short Ratio	1.27
Short Shares	0.8

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-42.3M
Average Volume	48,050.25x
Bv Per Share	10.42
CAPEX	$-293,000
Ch1m	-12.14
Ch1w	-3.96
Ch1y	18.52
Ch3m	11.72
Ch6m	4.73
Change	-8.73%
Change From Open	-7.56
Close	28.4
Days Gap	-1.27
Depreciation Amortization	1,342,000
Dollar Volume	5,344,989.1
Earnings Date	2026-08-12
Earnings Time	amc
EBIT	$-42.7M
EPS	$-20.19
F Score	2
FCF	$-35.4M
FCF EV Yield	-30.48x
FCF Per Share	$-10.18
Financing CF	72,609,000
Fiscal Year End	December
Founded	2,002
Goodwill	24,681,000
Income Tax	$-7.4M
Investing CF	-5,430,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2025-07-02
Last Split Type	Reverse
Last10k Filing Date	2026-03-19
Ma150	24.99
Ma150ch	3.72%
Ma20	26.84
Ma20ch	-3.41%
Net CF	32,095,000
Next Earnings Date	2026-08-12
Open	28.04
Optionable	No
Position In Range	11.35
Ppne	12,456,000
Price Date	2026-07-24
Relative Volume	4.29x
Revenue	27,701,000x
SBC By Revenue	24.85x
Share Based Comp	6,883,000
Tax By Revenue	-26.67x
Tr6m	4.73%
Us State	North Carolina
Volume	206,211
Z Score	-0.83

Pelthos Therapeutics Inc. (PTHS)

Coverage state: Market snapshot only — no published research

Generate the first PTHS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PTHS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PTHS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PTHS

Frequently asked questions